United States · Resolution · HRES
H.Res. 1285 (119th)
Expressing the sense of the House of Representatives that over 25 years of real-world evidence and hundreds of peer-reviewed studies proving that mifepristone is safe and effective should be respected, and law and policy governing access to lifesaving, time-sensitive medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science.
Introduced
14 May 2026
Last action
—
Status
Referred to the House Committee on Energy and Commerce.
Sponsors
—
Subjects
Discovery layer
Source updated
21 August 2026
Records
Official resolution H.Res. 1285 (119th) from United States at United States Congress. Dated 14 May 2026. Status: Referred to the House Committee on Energy and Commerce..
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
1 official file
Introduced in House
Introduced in House
Introduced in House · EN · 14 May 2026
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/119th-congress/house-resolution/1285
- Open data entity: https://api.congress.gov/v3/bill/119/hres/1285